Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial - Wikidata - awgldk - TriplyDB

Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

http://www.wikidata.org/entity/Q28212485

about

sameAs

Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians.Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention Elderly patients with myocardial infarction selected for conservative or invasive treatment strategy.An overview of PCI in the very elderly Coronary interventions in the elderly Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty Outcomes for mitral valve surgery among Medicare fee-for-service beneficiaries, 1999 to 2008.The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction.Intracoronary abciximab use in patients undergoing PCI at a community hospital: a single operator experience.Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.Review of the treatment of acute coronary syndrome in elderly patients.The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary.The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction.Impact of transradial coronary intervention on bleeding complications in octogenarians.Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome.Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention.Prehospital diagnosis in STEMI patients treated by primary PCI: the key to rapid reperfusion.Impact of abciximab in elderly patients with high-risk acute coronary syndrome undergoing percutaneous coronary intervention: an observational registry study.Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network.Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention.Age-based differences of percutaneous coronary intervention in the drug-eluting stent era.Improved short and long term survival associated with percutaneous coronary intervention in the elderly patients with acute coronary syndrome.ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome Antithrombotic Pharmacotherapy in the Elderly: General Issues and Clinical Conundrums Transfer for primary angioplasty in elderly patients with acute myocardial infarction

P2860

Q33764739-8D5B2F26-558F-445A-BD90-7621363D1E7D Q34194271-11B2E696-794F-4FA5-8F2E-A66F8E676444 Q35024306-EC93B13E-B060-43D7-B4A4-FDFCA4DB7BA5 Q35378992-316C1273-BA55-4257-97CE-5EE6D9741AB4 Q35772262-468C78E3-C092-424F-9503-C84DB0BEBF67 Q36095614-21EB2E18-9332-40EC-8794-AE8ADF0301BB Q36103900-55ADA1F3-52E2-4904-A487-68370F06081A Q36182190-B35C4E4A-C8C4-4124-B22C-2F270298211E Q36805340-088334A1-0860-411B-969C-92DA35A63FA7 Q37104143-095CE473-4746-4B17-AB97-919C404270DF Q37138914-C8C17072-2FD1-4B1A-A2DB-D302CE9A906D Q37240720-CD56EE01-4725-469A-B6A5-B3B32898EEAE Q37448924-D2726ABF-E05F-4D41-B7EB-1CCC038640A6 Q37599599-20A2B98A-4D37-4DC6-B7EB-41CE98FA8A7D Q37953885-BF0C4046-88BF-4DF9-ADA5-C1BE33E0726C Q38817242-2068BC53-3282-4E76-A90D-911EBD9300F0 Q39730277-967625DA-60DB-40F2-B248-834CBCE11A45 Q40890811-35348667-B65B-491B-B0D4-5B72597CB3E9 Q41265453-FD43E9B2-D20A-4BD6-B92B-7396BC25DAEA Q41538436-8B8D3139-F7C4-4DCC-9E69-7A0A3529E85D Q41557516-FC2D3F50-7FB1-4D1D-870B-53AA1343C080 Q43049921-2CBFF171-8C6C-4F44-BA2B-A17A53C5359A Q44985681-C2088C3D-5A09-4C9C-B6F4-62D4CE5E6CF0 Q48574965-63DBD96B-43D5-4EFF-A540-84EA74B09406 Q51032637-933058E9-FE0D-4B4D-A604-26C2D1B8F303 Q51124263-29938DE1-DFB2-4C53-9EFF-572BF72DF2B4 Q55379923-6FE128C1-C1A5-4FF6-B1EF-8E4B4DE61C8C Q57764209-FC575B19-D15E-4CE7-AF53-C875DAA85D3A Q57764364-60493FFB-4AFC-4CAC-A260-9C5245E966EF Q58088723-106AC4D5-80E5-4EBC-A6D8-AEF779193D55

P2860

Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

http://www.wikidata.org/entity/Q28212485

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@ast

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@en

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@nl

type

label

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@ast

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@en

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@nl

prefLabel

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@ast

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@en

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@nl

P1433

Q28212485-2AC653B5-95E4-4841-8611-213C072C7530

P1476

Q28212485-B33CC51B-FA82-4641-BC39-4F0611530D8A

P2093

Q28212485-1CD022EF-C771-4108-8C6D-D16AF789C33D

Q28212485-3F04A95E-3EBD-4F17-964E-CE954404A60E

Q28212485-65A1071A-A1D5-467D-95B5-AB83AC9BEB8C

Q28212485-847DF57B-4F81-4E9A-8237-C8C0579B93CF

Q28212485-8B2FAC2D-4704-4DEF-A394-46C577F884C0

Q28212485-93417777-AC02-43BB-981F-BE6227911443

Q28212485-A23A1CDB-68B1-4A3C-B8AF-A2DDC5400CD0

Q28212485-B1164464-A8E2-4F38-A93E-DE45035F8439

Q28212485-BEE6B4C6-9124-42DE-96E7-995B88E7E7BC

Q28212485-F06B35F7-4043-4C8D-A523-D475F1399EA7

P304

Q28212485-99EC7B26-065B-4C3F-81DB-728947156763

P31

Q28212485-9AFFF542-1073-4E30-993D-95F41F0EAF82

P3181

Q28212485-263D1504-458D-4744-9333-13DBC8743A99

P356

Q28212485-4D61F589-0124-4A6A-9310-02960CDFF804

P407

Q28212485-700B6493-D2BE-485D-9155-5C57D42236C4

P433

Q28212485-1645B885-035D-43DF-BD61-79A9538C22A9

P478

Q28212485-245F3E40-22B9-4D20-90A8-A83CB78C12EB

P50

Q28212485-C0316E0C-762D-410F-AB23-19EB4DA7D72E

P577

Q28212485-A2BC5191-7220-4D69-BE1D-C282762CBDEA

P5875

Q28212485-496AD357-1C4B-4BB7-899C-F948E127F4A0

P698

Q28212485-75922DFE-5631-452A-94FD-6EDFC35C25DA

P921

Q28212485-B3891FCD-F415-4D53-B629-5559DC88DE88

Q28212485-CFAA72F9-83E8-42BE-B65C-0CCA00D1E08D

P3181

P356

01.CIR.0000142862.98817.1F

P1433

P1476

Outcome in elderly patients un ...... Complications (CADILLAC) trial

@en

P2093

Alexandra J Lansky

http://www.w3.org/2001/XMLSchema#string

Cindy L Grines

http://www.w3.org/2001/XMLSchema#string

David A Cox

http://www.w3.org/2001/XMLSchema#string

Eulogio Garcia

http://www.w3.org/2001/XMLSchema#string

Giulio Guagliumi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Musumeci

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

James E Tcheng

http://www.w3.org/2001/XMLSchema#string

John J Griffin

http://www.w3.org/2001/XMLSchema#string

Mark Turco

http://www.w3.org/2001/XMLSchema#string

P304

1598-604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2686573

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.CIR.0000142862.98817.1F

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8359447

http://www.w3.org/2001/XMLSchema#string

P698

15353506

http://www.w3.org/2001/XMLSchema#string

P921